Preoperative chemotherapy and radiation therapy for squamous cell carcinoma of the maxillary sinus

Japanese Journal of Clinical Oncology

Volumn 35, Issue 11, 2005, Pages 633-638

  Isobe, Koichi ^a   Uno, Takashi ^a   Hanazawa, Toyoyuki ^a   Kawakami, Hiroyuki ^a   Yamamoto, Seiji ^a   Suzuki, Homare ^a   Iida, Yumiko ^a   Ueno, Naoyuki ^a   Okamoto, Yoshitaka ^a   Ito, Hisao ^a  

^a CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Chemotherapy; Maxillary sinus carcinoma; Prognostic factor; Radiation therapy; SCC

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; PEPLEOMYCIN;

ADULT; AGED; ARTICLE; BRAIN NECROSIS; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; KERATITIS; MAJOR CLINICAL STUDY; MALE; MAXILLA SINUS CARCINOMA; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; OPTIC NERVE DISEASE; PREOPERATIVE TREATMENT; PROGNOSIS; RETINITIS; RETROSPECTIVE STUDY; SKIN DEFECT; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; MALE; MAXILLARY SINUS NEOPLASMS; MIDDLE AGED; NEOADJUVANT THERAPY; PEPLOMYCIN; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 30444459015     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyi178     Document Type: Article

References (25)

1. Number of death and proportional mortality rates from malignant neoplasms by site in Japan (2001). In: Nomura K, editor. Cancer Statistics in Japan 2003. Tokyo: Foundation for promotion of cancer research 2003;36-9.
2. Ang KK, Garden AS, Morrison WH. Sinonasal cancer. In: Gunderson LL, Tepper JE, editors. Clinical Radiation Oncology. Philadelphia: Churchill Livingstone Inc., 2000;504-18.
3. Sato Y, Morita M, Takahashi H, Watanabe N, Kirikae I. Combined surgery, radiotherapy, and regional chemotherapy in carcinoma of the paranasal sinuses. Cancer 1970;25:571-9.
4. Sakai S, Hohki A, Fuchihata H, Tanaka Y. Multidisciplinary treatment of maxillary sinus carcinoma. Cancer 1983;52:1360-4.
5. Sakata K, Aoki Y, Karasawa K, Nakagawa K, Hasezawa K, Muta N, et al. Analysis of the results of combined therapy for maxillary carcinoma. Cancer 1993;71:2715-22.
6. Itami J, Uno T, Aruga M, Ode S. Squamous cell carcinoma of the maxillary sinus treated with radiation therapy and conservative surgery. Cancer 1998;82:104-7.
7. Nishino H, Miyata M, Morita M, Ishikawa K, Kanazawa T, Ichimura K. Combined therapy with conservative surgery, radiotherapy, and regional chemotherapy for maxillary sinus carcinoma. Cancer 2000;89:1925-32.
8. Yoshimura RI, Shibuya H, Ogura I, Miura M, Amagasa T, Enomoto S, et al. Trimodal combination therapy for maxillary sinus carcinoma. Int J Radiat Oncol Biol Phys 2002;53:656-63.
9. Hayashi T, Nonaka S, Bandoh N, Kobayashi Y, Imada M, Harabuchi Y. Treatment outcome of maxillary sinus squamous cell carcinoma. Cancer 2001;92:1495-503.
10. Nibu KI, Sugasawa, M, Asai M, Ichimura K, Mochiki M, Terahara A, et al. Results of multimodality therapy for squamous cell carcinoma of maxillary sinus. Cancer 2002;94:1476-82.
11. Blanco AI, Chao KSC, Ozyigit G, Adli M, Thorstad WL, Simpson JR, et al. Carcinoma of paranasal sinuses: Long term outcomes with radiotherapy. Int J Radiat Oncol Biol Phys 2004;59:51-8.
12. Lorusso P, Tapazoglou E, Kish JA, Ensley JF, Cummings G, Kelly J, et al. Chemotherapy for paranasal sinus carcinoma. Cancer 1988;62:1-5.
13. Bjork-Eriksson T, Mercke C, Petruson B, Ekholm S. Potential impact on tumor control and organ preservation with cisplatin and 5-fluorouracil for patients with advanced tumors of the paranasal sinuses and nasal fossa. Cancer 1992;70:2615-20.
14. Rosen A, Vokes EE, Scher N, Haraf D, Weichselbaum RR, Panje WR. Locoregionally advanced paranasal sinus carcinoma. Favorable survival with multimodality therapy. Arch Otolaryngol Head Neck Surg 1993;119:743-6.
15. Lee MM, Vokes EE, Rosen A, Witt ME, Weichselbaum RR, Haraf DJ. Multimodality therapy in advanced paranasal sinus carcinoma: Superior long-term results. Cancer J Sci Am 1999;5:219-23.
16. Licitra L, Locati LD, Cavina R, Garassino I, Mattavelli F, Pizzi N, et al. Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer. Ann Oncol 2003;14:367-72.
17. American Joint Committee on Cancer. AJCC Cancer Staging Handbook, 5th ed. Philadelphia: Lippincott Williams & Wilkins Inc. 1998;51-5.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
19. Cox DR. Regression model and life-tables. J R Stat Soc 1972;34:187-220.
20. Amendola BE, Eisert D, Hazra TA, King ER. Carcinoma of the maxillary antrum: Surgery or radiation therapy? Int J Radiat Oncol Biol Phys 1981;7:743-6.
21. Jiang GL, Ang KK, Peters LJ, Wendt CD, Oswald MJ, Goepfert H. Maxillary sinus carcinomas: Natural history and results of postoperative radiotherapy. Radiother Oncol 1991;21:193-200.
22. Paulino AC, Marks JE, Bricker P, Melian E, Reddy SP, Emami B. Results of treatment of patients with maxillary sinus carcinoma. Cancer 1998;83: 457-65.
23. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: Three meta-analyses of updated individual data. Lancet 2000;355: 949-55.
24. Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma: Are we making progress? Cancer 2001;92: 3012-29.
25. Ozyigit G, Chao KS. Paranasal sinuses and nasal cavity. In: Chao KS, Ozyigit G, editors. Intensity Modulated Radiation Therapy for Head and Neck Cancer. Philadelphia: Lippincott Williams & Wilkins Inc. 2002; 50-67.